摘要
目的:探讨肌红蛋白(Mb)、胱抑素C(CysC)联合改良HEART评分法在鉴别诊断急诊心源性胸痛危险分层的临床价值。方法:选择369例我院接诊的急诊胸痛患者,其中271例为心源性胸痛(心源性胸痛组),98例为非心源性胸痛(非心源性胸痛组)。均进行血清Mb、CysC检测和改良HEART评分、传统HEART评分评估,分析Mb、CysC联合改良HEART评分对心源性胸痛鉴别价值。结果:心源性胸痛组血清Mb、CysC水平、改良HEART评分、传统HEART评分均高于非心源性胸痛组(P<0.05),Logistic回归分析Mb、CysC、改良HEART评分与心源性胸痛的发生密切相关(P<0.01)。受试者工作特征曲线(ROC)分析结果示Mb、CysC、改良HEART评分、Mb+CysC+改良HEART评分鉴别心源性胸痛的曲线下面积(AUC)分别为0.783、0.737、0.872、0.933。结论:联合Mb、CysC和改良HEART评分可提高对急诊胸痛病因鉴别的准确率,指导急诊胸痛危险分层。
Objective:To investigate the clinical value of myoglobin(Mb), cystatin C(Cys C) combined with modified HEART score in the differential diagnosis of acute cardiogenic chest pain risk stratification. Method: Three hundred and sixty-nine patients with acute chest pain in our hospital were selected, among which 271 were cardiac chest pain(cardiac chest pain group) and 98 were non-cardiac chest pain(non-cardiac chest pain group). Mb and Cys C tests, improved HEART score and traditional HEART score were performed on all patients, and the value of Mb and Cys C combined improved HEART score in the identification of cardiogenic chest pain was analyzed. Result: The levels of serum Mb, Cys C, modified HEART score and traditional HEART score in the cardiogenic chest pain group were all higher than those in the non-cardiogenic chest pain group(P<0.05). Logistic regression analysis showed that Mb, Cys C and improved HEART score were correlated with the occurrence of cardiogenic chest pain(P<0.01). The Receiver operator characteristics curve(ROC) analysis results showed that the area under the curve(AUC) of Mb, Cys C, modified HEART score and Mb+Cys C+ modified HEART score for the identification of cardiogenic chest pain were 0.783, 0.737, 0.872, 0.933, respectively. Conclusion: The combination of Mb, Cys C and modified HEART score can improve the accuracy of identifying the etiology of chest pain in emergency, and guide the risk stratification of chest pain in emergency.
作者
李庆
方凯
张成伟
龙琴
李翠翠
LI Qing;FANG Kai;ZHANG Chengwei;LONG Qin;LI Cuicui(Department of Emergency,the Second Affiliated Hospital of Chengdu Medical College·416 Hospital of Nuclear Industry,Chengdu,610051,China;Department of Cardiovascular Medi-cine,the Second Affiliated Hospital of Chengdu Medical College·416 Hospital of Nuclear In-dustry;Department of Nephrology,the Second Affiliated Hospital of Chengdu Medical College·416 Hospital of Nuclear Industry)
出处
《临床急诊杂志》
CAS
2020年第5期402-408,共7页
Journal of Clinical Emergency